Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma

被引：0
作者：
Laurence Legros
Alina Pascale
Catherine Guettier
Pirayeh Eftekhari
Yasmina Ben Merabet
Maryse Stang
Rachel Bossevot
Emma Goldschmidt
Ayhan Ulusakarya
Stephane Morisset
Maïté Lewin
Didier Samuel
Olivier Rosmorduc
机构：
[1] Hôpital Bicêtre,Department of Clinical Hematology
[2] AP-HP,Hepato
[3] INSERM UMRS-MD-1197,Biliary Department
[4] Université Paris-Saclay,Anatomic Pathology Department
[5] France Intergroupe Syndromes Myéloprolifératifs (FIM),Medical Oncology Department
[6] Hôpital Paul Brousse,Radiology Department
[7] AP-HP,undefined
[8] Hôpital Bicêtre,undefined
[9] AP-HP,undefined
[10] Hôpital Paul Brousse,undefined
[11] AP-HP,undefined
[12] Independent Biostatistician,undefined
[13] Hôpital Paul Brousse,undefined
[14] AP-HP,undefined
[15] INSERM U1193,undefined
[16] Université Paris-Saclay,undefined
[17] Sorbonne Université,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2023年 / 91卷
关键词：
Hepatocellular carcinoma; Lenvatinib; Antiangiogenic drugs; Erythrocytosis; Erythropoietin; Thromboprophylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：337 / 344
页数：7
相关论文
共 135 条
[111]  
Leyland-Jones B(undefined)undefined undefined undefined undefined-undefined
[112]  
Bondarenko I(undefined)undefined undefined undefined undefined-undefined
[113]  
Nemsadze G(undefined)undefined undefined undefined undefined-undefined
[114]  
Miao S(undefined)undefined undefined undefined undefined-undefined
[115]  
Wang SM(undefined)undefined undefined undefined undefined-undefined
[116]  
Cheng X(undefined)undefined undefined undefined undefined-undefined
[117]  
Zhihong Y(undefined)undefined undefined undefined undefined-undefined
[118]  
Baocun S(undefined)undefined undefined undefined undefined-undefined
[119]  
Xiulan Z(undefined)undefined undefined undefined undefined-undefined
[120]  
Westphal G(undefined)undefined undefined undefined undefined-undefined
567891011121314